Phase I trial of intravenous AFN 1720, the pro-drug of AFN 1252.
Phase of Trial: Phase I
Latest Information Update: 11 Oct 2015
Price : $35 *
At a glance
- Drugs Afabicin (Primary)
- Indications Bacterial infections; Staphylococcal infections
- Focus Adverse reactions; Pharmacokinetics
- 12 Nov 2013 Results are expected in the next few weeks, according to an Affinium Pharmaceuticals media release.
- 12 Nov 2013 Status changed from recruiting to active, no longer recruiting, as reported by an Affinium Pharmaceuticals media release.
- 12 Sep 2013 New trial record